Arbutus Biopharma Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ABUS Nasdaq 2836 www.arbutusbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arbutus Biopharma Corporation

Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share - Aug 24th, 2026 5:30 am
Sector Update: Healthcare Stocks Advance in Afternoon Trading - Aug 21st, 2026 11:43 am
Arbutus Biopharma shares jump after unveiling $230 million share buyback plan - Aug 21st, 2026 7:32 am
ABUS Stock Surges 10% Today — What’s Driving This Super Rally? - Aug 21st, 2026 6:56 am
Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer - Aug 21st, 2026 5:30 am
Moderna’s Newfound War Chest Opens Door for 4 Strategic Acquisition Targets - Aug 20th, 2026 5:35 am
Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Aug 12th, 2026 5:30 am
Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage? - Aug 10th, 2026 6:18 pm
MRNA Q2 Earnings Meet, Stock Down on Norovirus Vaccine Setback - Jul 31st, 2026 12:04 pm
Pfizer (PFE) Faces Expanded Vaccine Lawsuits On A Fair Value Narrative That Still Sees Upside - Jul 22nd, 2026 3:08 pm
Pfizer (PFE) Faces New International Patent Lawsuits Over Covid 19 Vaccine - Jul 20th, 2026 9:09 am
Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advances - Jul 17th, 2026 4:07 am
ABUS Stock On Track For Best Day In About Two Months — What’s The Moderna Connection? - Jul 16th, 2026 12:41 pm
Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders - Jul 16th, 2026 5:30 am
Arbutus Biopharma (ABUS) Joins Russell Defensive Indexes And Exits Value Benchmarks - Jul 9th, 2026 4:11 pm
ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week - Jul 7th, 2026 12:28 pm
Arbutus Biopharma Corporation (ABUS) Reports Q1 2026 Results - Jun 13th, 2026 12:06 pm
Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update - May 13th, 2026 5:30 am
The Zacks Analyst Blog Highlights Moderna, Merck and Vertex Pharmaceuticals - May 4th, 2026 12:49 am